Pro 2013-018 (Jianfeng Group's Announcement on Issuance of Corporate Bonds in 2013)-3
Release time:
2020-08-05
16 , debt service method: using single interest on an annual basis, excluding compound interest, overdue no additional interest. Interest is paid once a year, the principal is repaid once due, and the last interest is paid with the payment of the principal. If the bondholder exercises the resale option at the end of 3 , the face value of the resale portion of the bond plus the interest for year 3 will be paid together on the investor's resale payment date.
17 , principal payment date: 2018 6 July 5 (in case of legal holidays or rest days, it will be postponed to the following working days). If the investor exercises the option of resale, the payment date of part of the bonds sold back will be 2016 6 May 5 (in case of legal holidays or rest days, it will be postponed to the following 1 working days).
18 , Guarantee: This corporate bond is provided by Tianjin Tianshili Group Co., Ltd. with full unconditional and irrevocable joint and several liability guarantee .
19 , credit rating, credit rating agency and follow-up rating arrangement: is comprehensively assessed by United Credit Rating Co., Ltd. , the credit rating of the current corporate bonds is AA + , and the main credit rating of the issuer is AA .
According to the relevant regulations of the regulatory authorities and the relevant requirements of United Rating for tracking rating, United Rating will conduct a regular tracking rating on this bond within 2 months after the issuer announces the annual report each year during the effective duration of this bond, and will conduct a regular tracking rating on according to relevant conditions during the duration of this bond.
The issuer shall provide relevant financial reports and other relevant information as required by the Joint Rating Tracking Rating Information List. The issuer shall promptly notify the joint rating and provide relevant information in the event of major changes or major events that may have a significant impact on the credit rating.
20 , Purpose of raising funds: This issue of corporate bonds is intended to be used to repay part of the company's debt and replenish the company's liquidity.
21 , Sponsor, Lead Underwriter, Bond Trustee: Zheshang Securities Co.
22 , underwriting method: is organized by the lead underwriter to underwrite the underwriting group, is underwritten by balance underwriting for the part that is finally undersubscribed for less than .1 billion yuan.
23 , proposed place of listing: Shanghai Stock Exchange.
24 , Listing Arrangements: After the issuance, the issuer will apply to the SSE for the listing and trading of the bonds as soon as possible. Specific listing time will be announced separately.
25 , new pledge repurchase: the long-term credit rating of the issuer is AA , and the credit rating of the current bond is AA + , which meets the basic conditions for conducting new pledge repurchase transactions. the relevant application for new pledge repurchase of the current bond still needs the final approval of the relevant departments, and the specific conversion rate and other matters shall be implemented in accordance with the relevant regulations of the registered company.
26 , Tax Tips: According to the relevant national tax laws and regulations, the tax payable by investors investing in this bond shall be borne by the investors.
27 , Timing related to the issuance of this bond:
Trading Day |
Work Items |
T-2 Day ( 201 3 6 July 3 Day) |
Published Prospectus and Its Summary, Issue Announcement , Credit Rating Report |
T-1 ( 201 3 March 4 ) |
Offline Inquiry Determines Par Rate |
T Day ( 201 3 Year 6 September 5 Day) |
Announces Final Par Rate Online Subscription Date Offline Subscription Start Date Remaining Part of Online Subscription Dial Back to Offline Issuance (If Any) |
T +1 Date ( 201 3 6 April 6 Day) |
Offline Subscription Day |
T +2 Day ( 201 3 6 August 7 Day) |
Offline Subscription Deadline all investors subscribed offline on the day of shall not be later than the day of 1 6 : before 00 , the subscription money will be transferred to the special collection account |
T +3 ( 201 3 6 January 13 ) |
offline issue registration date, the lead underwriter will register the offline subscription data on the day 10: before 30 , submit it in written and electronic data to Shanghai Stock Exchange to publish the release results announcement |
T +4 ( 201 3 6 October 14 ) |
sponsor (lead underwriter) transfers money to issuer, issue ends |
Note: the above date is the trading day. In the event of a major emergency affecting the issuance, the issuer and the sponsor (lead underwriter) will promptly announce and modify the issuance schedule.
2. Offline Interest Rate Inquiry to Institutional Investors
1 , Offline Investors
This offline interest rate inquiry is aimed at institutional investors (except those prohibited by laws and regulations) who have opened qualified securities accounts in registered Company .
2 , interest rate inquiry interval and coupon rate determination method
The coupon rate inquiry interval of this bond is 4.60 - 5.40 , The final coupon rate is determined by the issuer and the sponsor (lead underwriter) within the above interest rate inquiry interval according to the offline inquiry results, fixed for the duration of the bond. The bonds bear interest on an annual basis at simple interest, excluding compound interest, and interest is not charged for overdue periods. The coupon rate of the current bond is fixed for the first 3 years of the bond's life. If the issuer exercises the option to increase the coupon rate, the annual coupon rate for 2 years after the duration of the bonds that have not been resold will be 3 year coupon rate plus the adjustment basis point before the duration of the bonds, and will be fixed for 2 years after the duration of the bonds. If the issuer does not exercise the option to increase the coupon rate, the coupon rate of the portion of the bonds that have not been resold will remain unchanged after the duration of the 2 .
3 , Inquiry Time
The offline interest rate inquiry time for this issue of bonds is 201 3 6 4 ( T-1 ), institutional investors participating in the inquiry must be on 201 3 6 4 ( T-1 ) 10 : 00 - 15:00 faxes the "Application Form for Offline Interest Rate Inquiry and Application for Purchase" (see Schedule 1) to the sponsor (lead underwriter).
4, Inquiry Method
(1 ) Fill in the Application Form for Offline Interest Rate Inquiry and Application Purchase
Institutional investors who intend to participate in offline inquiry and subscription can download the Application Form for Offline Interest Rate Inquiry andApplication Purchase from the website listed in the issuance announcement (see schedule) , and fill in correctly as required.
should pay attention to filling in the "Application Form for Offline Interest Rate Inquiry andApplication for 421 Purchase": ① should fill in the inquiry interest rate
within the interest rate inquiry range specified in the issuance announcement, and the inquiry interest rate may not be continuous; ② Each "Application Form for Online Interest Rate Inquiry and
Application forPurchase" can fill in up to 5 inquiry interest rates; ③ When filling in the inquiry interest rate, it is accurate to
0.01%; ④ Fill in the inquiry interest rate from low to high and in sequence;
⑤ The total subscription amount at each inquiry interest rate shall not be less than
100.46 million yuan (including 100 .48 million yuan) and shall be an integer multiple of 100 .5 million yuan (1,000 hands); ⑥ The total subscription amount corresponding to each inquiry interest rate is when the finally determined coupon rate is not lower than the inquiry interest rate, maximum investment demand of institutional investors
.(
2) Institutional investors who submit to participate in the inquiry should be on
2013 September 4
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page